Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
6.95
-0.15 (-2.11%)
May 8, 2026, 4:00 PM EDT - Market closed
Kyntra Bio Market Cap
Kyntra Bio has a market cap or net worth of $28.13 million as of May 11, 2026. Its market cap has decreased by -12.90% in one year.
Market Cap
28.13M
Enterprise Value
-41.28M
1-Year Change
-12.90%
Ranking
Category
Stock Price
$6.95
Market Cap Chart
Since November 14, 2014, Kyntra Bio's market cap has decreased from $1.22B to $28.13M, a decrease of -97.70%. That is a compound annual growth rate of -28.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 28.10M | -20.85% |
| Dec 31, 2025 | 35.50M | -33.52% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
| Nov 14, 2014 | 1.22B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 30.30M |
| BriaCell Therapeutics | 29.77M |
| Quantum BioPharma | 29.75M |
| Tempest Therapeutics | 28.54M |
| Lisata Therapeutics | 28.45M |
| Neuphoria Therapeutics | 28.36M |
| Dyadic International | 27.93M |
| Barinthus Biotherapeutics | 27.37M |